FLT3 and acute myeloid leukemia: To this end, FLT3 mutations are found in roughly 30% of acute myeloid leukemia (AML) cases and, to a lesser extent, in acute lymphoblastic leukemia (ALL), making it an important therapeutic target [1,2].